Chinese expert consensus on ultrasound hyperthermia for oral and maxillofacial head and neck squamous cell carcinoma

doi:10.19438/j.cjoms.2020.03.001

China Journal of Oral and Maxillofacial Surgery ›› 2020, Vol. 18 ›› Issue (3): 193-198.doi: 10.19438/j.cjoms.2020.03.001

• Expert Consensus • Previous Articles Next Articles

Chinese expert consensus on ultrasound hyperthermia for oral and maxillofacial head and neck squamous cell carcinoma

JU Hou-yu¹, ZHENG Jia-wei¹, SUN Mo-yi², TANG Zhan-gui³, YANG Dao-ke⁴, RAN Wei⁵, BU Rong-fa⁶, SHANG Wei⁷, MENG Jian⁸, WU He-ming⁹, XI Qing⁶, YANG Kai¹⁰, WANG Jun¹¹, WU Yun-teng¹, REN Guo-xin¹, GUO Wei¹

1. Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine. Shanghai 200011;
2. Department of Oral and Maxillofacial Surgery, School of Stomatology, Air Force Military Medical University. Xi'an 710032, Shaanxi Province;
3. Department of Oral and Maxillofacial Surgery, Xiangya School of Stomatology, Central South University. Changsha 410013, Hunan Province;
4. Department of Radiotherapy, the First Affiliated Hospital of Zhengzhou University. Zhengzhou 450052, Henan Province;
5. Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Sun Yat-sen University. Guangzhou 510080, Guangdong Province;
6. Department of Oral and Maxillofacial Surgery, the General Hospital of the People's Liberation Army. Beijing 100853;
7. Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Qingdao University Medical College. Qingdao 266000, Shandong Province;
8. Department of Oral and Maxillofacial Surgery, the Affiliated Hospital of Xuzhou Medical University. Xuzhou 221009, Jiangsu Province;
9. Department of Oral and Maxillofacial Surgery, Stomatological Hospital Affiliated to Nanjing Medical University. Nanjing 210029, Jiangsu Province;
10. Department of Oral and Maxillofacial Surgery, First Hospital Affiliated to Chongqing Medical University. Chongqing 400016;
11. Department of Head and Neck Surgery, Gansu Cancer Hospital. Lanzhou 730050, Gansu Province;
12. Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangnan University. Wuxi 214041, Jiangsu Province, China

Received:2020-04-07 Revised:2020-04-10 Published:2020-04-30

Abstract

Abstract: Most patients with oral and maxillofacial malignancy, especially squamous cell carcinoma(SCC) are in the middle and advanced stages at diagnosis. Chemotherapy alone is difficult to benefit the survival of patients with advanced oral and maxillofacial SCC. Ultrasound hyperthermia is a new and effective treatment for malignant tumor, which is developing rapidly in addition to conventional treatment. However, at present, ultrasound hyperthermia has not been widely used in the treatment of oromaxillofacial head and neck SCC. Therefore, formation of an expert consensus on ultrasound hyperthermia for oromaxillofacial head and neck SCC is mandatory, in order to promote and standardize the clinical practice of ultrasound hyperthermia in this field, and improve the long-term survival rate and quality of life of patients.

Key words: Oral and maxillofacial region, Head and neck, Squamous cell carcinoma, Ultrasound hyperthermia, Combination therapy, Cavitation effect, Expert consensus

CLC Number:

R739.8

JU Hou-yu, ZHENG Jia-wei, SUN Mo-yi, TANG Zhan-gui, YANG Dao-ke, RAN Wei, BU Rong-fa, SHANG Wei, MENG Jian, WU He-ming, XI Qing, YANG Kai, WANG Jun, WU Yun-teng, REN Guo-xin, GUO Wei. Chinese expert consensus on ultrasound hyperthermia for oral and maxillofacial head and neck squamous cell carcinoma[J]. China Journal of Oral and Maxillofacial Surgery, 2020, 18(3): 193-198.

References

[1] The 11th Revision of the International Classification of Diseases (ICD-11)[S/OL]. World Health Organization, 2018. https://icd.who.int/browse11/l-m/en.
[2] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[3] Ghi MG, Paccagnella A, Ferrari D, et al.Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial[J]. Ann Oncol, 2017, 28(9):2206-2212.
[4] Zhong LP, Zhang CP, Ren GX, et al.Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma[J]. J Clin Oncol, 2013, 31(6):744-51.
[5] O'Reilly MA, Hynynen K. Emerging non-cancer applications of therapeutic ultrasound[J]. Int J Hyperthermia ,2015, 31(3): 310-318.
[6] Verhaart RF, Fortunati V, Verduijn GM, et al.CT-based patient modeling for head and neck hyperthermia treatment planning: manual versus automatic normal-tissue-segmentation[J]. Radiother Oncol, 2014, 111(1): 158-163.
[7] Falk MH, Issels RD.Hyperthermia in oncology[J]. Int J Hyperthermia, 2001, 17(1):1-18.
[8] Feyerabend T, Steeves R, Wiedemann GJ, et al.Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies[J]. Oncol, 1996, 53(3):214-220.
[9] Manaf NA, Aziz MN, Ridzuan DS, et al.Feasibility of A-mode ultrasound attenuation as a monitoring method of local hyperthermia treatment[J]. Med Biol Eng Comput, 2016, 54(6): 967-981.
[10] Takahashi I, Emi Y, Hasuda S, et al.Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors[J]. Surgery, 2002, 131(1 Suppl):S78-84.
[11] Yunoki T, Kariya A, Kondo T, et al.The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells[J]. Cancer Lett, 2013, 335(1): 52-57.
[12] Zhao J, Wang S, Liu N, et al.Correlation between the expression of Id-1 and hyperthermia-associated molecules in oral squamous cell carcinoma[J]. J Clin Pathol, 2013, 66(9): 758-763.
[13] Bai Z, Shi Y, Wang J, et al.Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer[J]. Oncotarget, 2017, 8(2): 3591-3599.
[14] Wang H, Mao L, Zhang T, et al.Altered expression of TIM-3, LAG-3, IDO, PD-L1, and CTLA-4 during nimotuzumab therapy correlates with responses and prognosis of oral squamous cell carcinoma patients[J]. J Oral Pathol Med, 2019, 48(8):669-676.
[15] Ju H, Mao L, Zhang L, et al.Ultrasound hyperthermia enhances chemo-sensitivity in oral squamous cell carcinoma by TRIF-mediated pathway[J]. J Oral Pathol Med, 2018, 47(10): 964-971.
[16] Ren G, Jv H, Tian Z, et al.Ultrasound hyperthermia induces apoptosis in head and neck squamous cell carcinoma: An in vitro study[J]. Med Oral Pathol Oral Cir Bucal, 2017, 22(3): e289-e296.
[17] Amichetti M, Graiff C, Fellin G, et al.Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I-II study[J]. Int J Radiat Oncol Biol Phys, 1993, 26(5):801-807.
[18] Nagashima K, Takagi R, Hoshina H.Effect of local hyperthermia on metastases in oral squamous cell carcinoma[J]. Int J Oral Maxillofac Surg, 2002, 31(1):84-89.
[19] 任国欣, 沈国峰, 陈亚珠, 等.晚期口腔颌面部恶性肿瘤超声热化疗的Ⅰ/Ⅱ期临床研究[J].临床肿瘤学杂志, 2011,16(3):244-248.
[20] 闫向勇,刘文超.热疗在肿瘤治疗中的研究进展[J].世界中西医结合杂志,2014,9(2):213-216.
[21] Ettinger KS, Ganry L, Fernandes RP.Oral cavity cancer[J]. Oral Maxillofac Surg Clin North Am, 2019, 31(1):13-29.
[22] Schwartz LH, Seymour L, Litière S, et al.RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group[J]. Eur J Cancer, 2016, 62:138-145.
[23] 侯会珍. 恶性肿瘤热疗致皮肤烫伤的原因与预防[A]//河南省护理学会.河南省肿瘤全科护理学术交流会议资料汇编[C].郑州:河南省护理学会,2005:233-234.
[24] 皋文君,刘砚燕,袁长蓉.国际肿瘤化疗药物不良反应评价系统-通用不良反应术语标准4.0版[J].肿瘤, 2012, 32(2):142-144.
[25] 任国欣,郭伟.局部热疗在头颈癌综合治疗中的应用[J].中国口腔颌面外科杂志, 2004, 2(1):60-63.
[26] Falchook AD, Green R, Knowles ME, et al.Comparison of patient- and practitioner-reported toxic effects associated with chemoradiotherapy for head and neck cancer[J]. JAMA Otolaryngol Head Neck Surg, 2016, 142(6):517-523.

Chinese expert consensus on ultrasound hyperthermia for oral and maxillofacial head and neck squamous cell carcinoma

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	GAO Jia-min, YAO Yan-li, WANG Yu-jue, ZHANG Zhi-yuan, SUN Shu-yang. Effect of docetaxel on cell pyroptosis of head and neck squamous cell carcinoma and its mechanism [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 105-111.
[2]	HAN Lin-zi, ZHOU Jian-hua, ZHAO Qian, DONG Lei, CHEN Zheng-gang, QIU Jian-zhong, YUAN Rong-tao. The regulation and mechanism of cancer-associated fibroblasts on tumor-infiltrating immune cells in head and neck squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 119-124.
[3]	QIU Yin-xiu, DAI Tian-guo, XU Bo, CHENG Jin-qiang, LIU Zhong-long. A new clinical classification of severe oromaxillofacial head and neck multi-space infections [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 125-130.
[4]	SHEN Meng-yuan, ZHANG Xue-ying, ZHAO Shan, XU Xin-chen, LI Xiao-dong, MENG Jian. Risk factors and clinical value of neutrophil-to-lymphocyte ratio in prediction of delirium after free flap surgery for head and neck cancer [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 131-136.
[5]	LIU Jiang-long, JIA Fang, WANG Xiao-rong, REYILAI Abudukeremu, WUERGULI Alifu, MAIMAITITUXUN Tuerdi. Diagnostic value of contrast-enhanced ultrasound in cervical lymph node metastasis from oral and maxillofacial squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 168-174.
[6]	REZIWANGULI·Yasen, MAIREPATI·Maiming, LI Chen-xi, GONG Zhong-cheng. Research progress in the role and mechanism of Porphyromonas gingivalis in promoting oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 186-190.
[7]	LAN Rong, RUAN Min, HAN Nan-nan, WANG Feng. Peri-implant squamous cell carcinoma appeared after implant-restoration in the left mandible: a case report [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(2): 203-205.
[8]	CHEN Wei-liang. Reconstruction of large head and neck defects with extended vertical lower trapezius island myocutaneous flap [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 1-10.
[9]	LI Xue-er, WANG Zheng-ye, TUERDI Maimaitituxun. Identification of HPV status in head and neck squamous cell carcinoma patients based on radiomics: diagnostic meta-analysis [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 69-74.
[10]	LIU Heng, DUAN Xiao-feng. Research progress of ferritinophagy and related genes FTH1 and NCOA4 in oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(1): 87-91.
[11]	GONG Xia, LI Jia, XIONG Ping, DING Ang-ang. Ultrasonography diagnosis of vascular tumors of the head and neck [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(6): 521-526.
[12]	ZHOU Yu, WENG Hai-yan, SI Cheng-yun, DUAN Xian-jie, AN Xing-fei, ZHANG Li-yu. Clinical study on the prognostic and risk stratification effect of the 8th revised TNM staging on patients with early oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(6): 571-576.
[13]	GONG Xia, LI Jia, XIONG Ping, DING Ang-ang. Ultrasonography diagnosis of head and neck vascular malformations [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 417-421.
[14]	YANG Hui-li, WANG Yu-fan, WANG Feng, SHEN Yue-hong, YANG Hong-yu. Comprehensive co-expression analysis revealed NLRP1 as a prognostic immune-associated gene in head and neck squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 429-436.
[15]	JI Ping-ping, LI Li, WU Yi-fan, HOU Li-li. Effect of transcutaneous electrical acupoint stimulation on myelosuppression in patients with oral squamous cell carcinoma after induction chemotherapy [J]. China Journal of Oral and Maxillofacial Surgery, 2022, 20(5): 455-460.